Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
2.910
0.00 (0.00%)
Apr 29, 2026, 11:35 AM EDT - Market open
Can-Fite BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -9.83 | -7.88 | -7.63 | -10.17 | -12.62 | |
| Depreciation & Amortization | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Loss (Gain) From Sale of Investments | 0 | 0.01 | -0.01 | 0.23 | -0.16 | |
| Stock-Based Compensation | 0.34 | 0.36 | 0.26 | 0.26 | 0.47 | |
| Other Operating Activities | 0.08 | 0.13 | -0.13 | 0.17 | 0.01 | |
| Change in Accounts Payable | 0.54 | 0.19 | -0.47 | -0.06 | 0.39 | |
| Change in Unearned Revenue | -0.41 | -0.35 | -0.74 | -0.81 | 1.4 | |
| Change in Other Net Operating Assets | 0.3 | -0.11 | 0.27 | -0.43 | 0.64 | |
| Operating Cash Flow | -8.95 | -7.64 | -8.44 | -10.8 | -9.86 | |
| Capital Expenditures | -0 | -0.01 | -0 | -0.01 | -0.01 | |
| Investment in Securities | - | 1.5 | 0.5 | 9.51 | -14.5 | |
| Investing Cash Flow | -0 | 1.5 | 0.5 | 9.5 | -14.51 | |
| Issuance of Common Stock | 9.64 | 7.22 | 9.14 | - | 21.76 | |
| Other Financing Activities | - | -0.51 | - | - | -1.31 | |
| Financing Cash Flow | 9.64 | 6.71 | 9.14 | - | 20.46 | |
| Foreign Exchange Rate Adjustments | 0.01 | -0.02 | 0.1 | -0.11 | 0.03 | |
| Net Cash Flow | 0.7 | 0.55 | 1.3 | -1.41 | -3.88 | |
| Free Cash Flow | -8.95 | -7.64 | -8.44 | -10.81 | -9.87 | |
| Free Cash Flow Margin | -2210.12% | -1133.83% | -1136.20% | -1334.57% | -1156.98% | |
| Free Cash Flow Per Share | -5.44 | -10.54 | -19.81 | -39.76 | -53.53 | |
| Cash Interest Paid | - | - | - | - | 0.02 | |
| Levered Free Cash Flow | -4.99 | -4.82 | -5.12 | -6.51 | -5.98 | |
| Unlevered Free Cash Flow | -4.99 | -4.82 | -5.12 | -6.51 | -5.98 | |
| Change in Working Capital | 0.43 | -0.27 | -0.94 | -1.3 | 2.43 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.